Latest news with #OptimaHealth
Glasgow Times
2 days ago
- Health
- Glasgow Times
Number of stress-related absences at Police Scotland
Figures obtained through a Freedom of Information (FOI) request have revealed the number of Police Scotland officers who were absent due to stress-related illness between 2022 and 2025. Data shows that 2584 cops called in sick to work over the issue during this period. Meanwhile, 1269 members of staff were also absent due to stress. Figures provided by the force show a year-on-year increase in the number of both officers and staff having to take time off due to suffering from stress. In 2022/23, Police Scotland recorded 692 officer absences and 349 staff absences. In 2023/24, that number rose to 763 officers and 395 members of staff. Again, in 2024/25, the figure increased to 868 cops and 434 staff members. READ NEXT: Glasgow police at 'breaking point' as 'desperate conditions' exposed Meanwhile, the total number for the 2025/26 period so far is 261 officers and 91 members of staff. Police Scotland noted that there are various services available to officers and staff suffering from stress. These include the Employee Assistance Programme (EAP), which is a confidential telephone helpline that is open 24/7, 365 days a year. EAP covers both work and personal issues. Employees, volunteers, retired officers, staff, and their direct family members over the age of 16 are all eligible to access the helpline. It is in place to provide them with confidential advice from qualified counsellors. Another service that is available is a Stress Risk Assessment. READ NEXT: More than 400,000 paramedic hours lost due to mental ill health This is for individuals who feel their health is being affected due to either work-related or personal issues. Managers and supervisors can support officers and staff by jointly carrying out a risk assessment using Police Scotland's Individual Stress Risk Assessment Questionnaire & Action Plan and the supporting guidance. If required, supervisors can then take action to support and monitor individuals who have either been identified or informed that they are displaying symptoms of stress. Finally, Police Scotland offers cops and staff access to what they have described as a 'mental health MOT,' also known as 'Your Wellbeing Assessment' (YWA). This is delivered through the force's occupational health providers. The main features of YWA include that it is open to all officers and members of staff, it is voluntary, secure, and confidential. The assessment is reviewed by a member of the Optima Health clinical team, and it is said to potentially lead to early identification of issues and the provision of tailored support. Deputy Chief Constable Alan Speirs said: "The health and welfare of our officers and staff remains one of Police Scotland's highest priorities, with enhanced provisions from both our Employee Assistance and Your Wellbeing Matters programmes. 'This will be further enhanced through the implementation of our new HR structure with increased resources within our Health and Wellbeing team. 'We also have a range of mechanisms in place to support our employees who are absent from work for any reason. 'We continue to work with our occupational health provider to support police officers and staff in their journey back to health and, subsequently, to work.'
Business Upturn
06-05-2025
- Business
- Business Upturn
Optima Health to acquire Care first
By GlobeNewswire Published on May 6, 2025, 16:00 IST Optima Health to acquire Care first, a leading provider of mental health services, for a net consideration of £15,000, adding c.£3.7 million revenue to the Group Acquisition provides Optima with increased scale in its Mental Health division and will complement its existing Employee Assistance Programme ('EAP') service offering, bringing over 1,000 new customers, and c.40 employees Aligns with strategy of consolidating margin accretive businesses in areas with significant existing expertise, creating additional growth opportunities and scale benefits LONDON, UK, 6 May 2025, Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, today announces that it has entered into an agreement to acquire the trade and assets of Care first ('Care first'), a leading provider of mental health services from Priory Group for a cash consideration of £350,000 (£15,000 net) on a cash free, debt free basis (the 'Acquisition'). The effective date will be 2 June 2025. The Acquisition will expand Optima Health's scale in the provision of mental health services, with Care first complementing the Group's existing EAP service offering. The deal will also expand Optima's customer base with the addition of over 1,000 new customers, presenting further cross selling opportunities of other occupational health and wellbeing solutions. Alongside this, the Acquisition brings additional specialist capabilities with approximately 40 experienced employees with a substantial network. This Acquisition aligns with Optima Health's strategic focus in the occupational health sector, consolidating margin accretive and value creating businesses in areas where we have significant expertise, creating additional growth opportunities and scale benefits with enhanced operating leverage. Further to the Acquisition, and as previously reported, there are significant opportunities to accelerate growth, and the Board will continue to evaluate bolt-on acquisitions and consolidation in the market. Jonathan Thomas, Chief Executive Officer of Optima Health, said: ' The acquisition of Care first demonstrates our ability to continue to execute on our communicated strategy. The business is strategically aligned with ours in a market we understand extremely well, creating opportunities for scale. We look forward to integrating the businesses and benefiting from the significant additional specialist capabilities and revenue growth opportunities, as we continue to evaluate further value-enhancing bolt-on opportunities in the market.' Financial considerations Under the terms of the agreement to acquire the entire trade and assets of Care first on a cash free, debt free basis, Optima Health will pay a consideration of £350,000 on completion, offset by an apportionment adjustment of £335,000, meaning a net consideration of £15,000. The Acquisition will be financed using the Group's existing financing facilities. In the 12 months to December 2024, Care first generated unaudited revenue of £4.4 million. Enquiries Optima Health Jonathan Thomas, CEO Heidi Giles, CFO +44(0)3300085113 [email protected] Nominated Adviser and Corporate Broker Panmure Liberum Limited Emma Earl / Will Goode / Mark Rogers Rupert Dearden +44 (0)20 3100 2000 UK Financial PR Adviser ICR Healthcare Mary-Jane Elliott / Angela Gray / Lindsey Neville [email protected] About Optima Health Optima Health is the UK's leading provider of occupational health and wellbeing services, directly influencing and improving people's lives for 25 years. Optima Health's incredible team of professionals quickly and effectively encapsulate client's needs, supporting organisations of all shapes and sizes. Through tailored solutions and innovative systems, Optima Health offers unparalleled clinical expertise to its clients. These solutions ensure that processes are simple and allow its clients to spend more time focusing on their employees driving a healthy, high-performing workplace. For more information visit Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Yahoo
13-02-2025
- Business
- Yahoo
Optima Health plc's (LON:OPT) Intrinsic Value Is Potentially 91% Above Its Share Price
Optima Health's estimated fair value is UK£3.31 based on 2 Stage Free Cash Flow to Equity Optima Health is estimated to be 48% undervalued based on current share price of UK£1.73 Does the February share price for Optima Health plc (LON:OPT) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by estimating the company's future cash flows and discounting them to their present value. This will be done using the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex. Remember though, that there are many ways to estimate a company's value, and a DCF is just one method. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. Check out our latest analysis for Optima Health We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (£, Millions) -UK£3.39m UK£13.2m UK£15.0m UK£16.4m UK£17.5m UK£18.5m UK£19.3m UK£20.1m UK£20.8m UK£21.4m Growth Rate Estimate Source Analyst x2 Analyst x2 Analyst x1 Est @ 9.08% Est @ 7.05% Est @ 5.62% Est @ 4.63% Est @ 3.93% Est @ 3.44% Est @ 3.10% Present Value (£, Millions) Discounted @ 7.7% -UK£3.1 UK£11.3 UK£12.0 UK£12.2 UK£12.1 UK£11.9 UK£11.5 UK£11.1 UK£10.7 UK£10.2 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = UK£100m After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.3%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 7.7%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = UK£21m× (1 + 2.3%) ÷ (7.7%– 2.3%) = UK£407m Present Value of Terminal Value (PVTV)= TV / (1 + r)10= UK£407m÷ ( 1 + 7.7%)10= UK£194m The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is UK£294m. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of UK£1.7, the company appears quite undervalued at a 48% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Optima Health as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.7%, which is based on a levered beta of 1.050. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Although the valuation of a company is important, it ideally won't be the sole piece of analysis you scrutinize for a company. It's not possible to obtain a foolproof valuation with a DCF model. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. What is the reason for the share price sitting below the intrinsic value? For Optima Health, we've compiled three fundamental elements you should look at: Financial Health: Does OPT have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk. Future Earnings: How does OPT's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the AIM every day. If you want to find the calculation for other stocks just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
